nakamura yukio

Osteoporosis, Locomotive syndrome and Joint disease centerProfessor
Osteoporosis, Locomotive syndrome and Joint disease centerManager

Member History

  • 日本軟骨代謝学会, 評議員
  • 日本骨代謝学会, 評議員
  • 日本小児整形外科学会, 評議員
  • 日本骨粗鬆症学会, 評議員
  • 日本リウマチ学会, 評議員
  • 日本人工関節学会, 評議員

Award

  • 2022
    第17回日本骨粗鬆症学会森井賞
  • 2022
    令和3年度 信州大学医学部学術奨励賞(2回)
    Japan
  • 2021
    日本骨代謝学会学術賞
    Japan
  • 2021
    ノバルティス・リウマチ医学賞
    Japan
  • 2020
    Albert Nelson Marquis Lifetime Achievement Award
  • 2019
    Top 10% most cited PLOS ONE papers published in 2017
  • 2019
    The Tohoku Journal of Experimental Medicine. TOP 30 Papers Downloaded in 2018(第6位) #Downloads:2294 times, Time Cited:2
    Japan
  • 2019
    Albert Nelson Marquis Lifetime Achievement Award
    Japan
  • 2018
    Albert Nelson Marquis Lifetime Achievement Award
  • 2018
    信州大学医学部整形外科同門会賞
    Japan
  • 2017
    Albert Nelson Marquis Lifetime Achievement Award
  • 2016
    日本骨粗鬆症学会研究奨励賞
    Japan
  • 2015
    第33回日本骨代謝学会ポスター口演賞
    Japan
  • 2014
    第23回遺伝医学セミナー最高得点受賞
    Japan
  • 2014
    平成25年度信州大学医学部学術奨励賞
    Japan
  • 2013
    第44回日本結合組織学会優秀演題賞
    Japan
  • 2013
    平成24年度信州大学医学部学術奨励賞
    Japan
  • 2012
    ASBMR/John Haddad Young Investigator Award.
  • 2012
    平成23年度信州大学医学部学術奨励賞
    Japan
  • 2011
    ASBMR/Young Investigator Travel Grant
  • 2011
    第117回中部日本整形外科災害外科学会奨励賞
    Japan
  • 2009
    第22回日本軟骨代謝学会賞
    Japan
  • 2008
    DePuy Spine Research Award, Pediatric Orthopaedic Society of North America
  • 2008
    ASBMR/Harold M. Frost Young Investigator Award
  • 2007
    Travel award: Gordon Research Conference; Cartilage Biology & Pathology
  • 2006
    Keystone Symposia on Molecular and Cellular Biology Award

Paper

  • Relationship between Stress Shielding and Optimal Femoral Canal Contact Regions for Short, Tapered-Wedge Stem Analyzed by 2D and 3D Systems in Total Hip Arthroplasty.
    Maeda T, Nakano M, Nakamura Y*, Momose T, Sobajima A, Takahashi J, Nakata K, Nawata M.
    J Clin Med, 2023, Not reviewed
    12, 3138
  • Nitric oxide is associated with fracture risk in Japanese women.
    Shiraki M, Kuroda T, Nakano M, Nakamura Y*, Saito M, Urano T.
    PLoS One, 2023, Not reviewed
    18, e0280854
  • Comparable efficacy of denosumab and romosozumab in patients with rheumatoid arthritis receiving glucocorticoid administration.
    Kobayakawa T, Miyazaki A, Kanayama Y, Hirano Y, Takahashi J, Suzuki T, Nakamura Y*.
    Mod Rheumatol., 2023, Not reviewed
    23, 96, 103
  • Distinct dietary risk factors for incident osteoporotic fractures in early and late postmenopausal phase women.
    Nakano M, Uenishi K, Nakamura Y*, Takahashi J, Shiraki M
    J Bone Miner Metab, 2023, Not reviewed
    41, 227, 238
  • Clinical and molecular features of patients with COL1-related disorders: Implications for the wider spectrum and the risk of vascular complications.
    Takeda R, Yamaguchi T, Hayashi S, Sano S, Kawame H, Kanki S, Taketani T, Yoshimura H, Nakamura Y, Kosho T.
    Am J Med Genet, 2022, Not reviewed
    188A, 2560, 2575
  • Verification of efficacy and safety of ibandronate or denosumab for postmenopausal osteoporosis after 12-month treatment with romosozumab as sequential therapy: The prospective VICTOR study.
    Kobayakawa T, Miyazaki A, Takahashi J, Nakamura Y*.
    BONNE, 2022, Not reviewed
    162, 116480
  • Comparable efficacy of denosumab and romosozumab in patients with rheumatoid arthritis receiving glucocorticoid administration.
    Kobayakawa T, Miyazaki A, Kanayama Y, Hirano Y, Takahashi J, Suzuki T, Nakamura Y*.
    Mod Rheumatol., 2022, Not reviewed
    roac014.
  • Effects of romosozumab with and without active vitamin D analog supplementation for postmenopausal osteoporosis.
    Kobayakawa T, Miyazaki A, Takahashi J, Nakamura Y*.
    Clin Nutr ESPEN, 2022, Not reviewed
    48, 267, 274
  • Peficitinib improves bone fragility by recovering bone turnover imbalance in arthritic mice.
    Sugawara S, Hanaoka K, Emori T, Takeshita N, Fujii Y, Nakano M, Suzuki T, Takahashi J, Nakamura Y*.
    J Pharmacol Sci., 2022, Not reviewed
    148, 134, 141
  • Efficacy of romosozumab for osteoporosis in a patient with osteogenesis imperfecta: A case report.
    Uehara M, Nakamura Y*, Nakano M, Miyazaki A, Suzuki T, Takahashi J.
    Mod Rheumatol Case Rep., 2022, Not reviewed
    6, 128, 133
  • Efficacy of denosumab therapy for a 12-year-old woman with Williams syndrome with osteoporosis and history of fractures: A case report.
    Uehara M, Nakamura Y*, Suzuki T, Nakano M, Takahashi J.
    J Med Case Rep, 2021, Not reviewed
    15, 594
  • Efficacy and Safety of Oral Ibandronate versus Intravenous Zoledronic Acid on Bone Metabolism and Bone Mineral Density in Postmenopausal Japanese Women with Osteoporosis.
    Uehara M, Nakamura Y*, Suzuki T, Nakano M, Takahashi J.
    J Clin Med, 2021, Not reviewed
    10, 5420
  • Associations of LRP5 and MTHFR Gene Variants with Osteoarthritis Prevalence in Elderly Women: A Japanese Cohort Survey Randomly Sampled from a Basic Resident Registry.
    Nakano M, Yui H, Kikugawa S, Tokida R, Sakai N, Kondo N, Endo N, Haro H, Shimodaira H, Suzuki T, Kato H, Takahashi J, Nakamura Y*.
    Ther Clin Risk Manag., 2021, Not reviewed
    17, 1065, 1073
  • MTHFR gene C677T polymorphism predicts progression of spinal osteoarthritis.
    Nakano M, Nakamura Y*, Urano T, Miyazaki A, Suzuki T, Watanabe K, Takahashi J, Shiraki M
    J Clin Endocrinol Metab., 2021, Not reviewed
    dgab591.
  • Short- to Mid-Term Clinical Outcomes of Posterior-Stabilized Cementless Total Knee Arthroplasty with Trabecular Metal Components.
    Momose T, Nakamura Y*, Nakano M, Maeda T, Morioka S, Sobajima A, Nakatsuchi Y, Takahashi J, Nawata M
    Ther Clin Risk Manag., 2021, Not reviewed
    17, 809, 816
  • Denosumab versus romosozumab for postmenopausal osteoporosis treatment.
    Kobayakawa T, Miyazaki A, Saito M, Suzuki T, Takahashi J, Nakamura Y*
    Sci Rep, 2021, Not reviewed
    11, 11801
  • Zinc Pharmacotherapy for Elderly Osteoporotic Patients with Zinc Deficiency in a Clinical Setting
    Nakano M, Nakamura Y*,Miyazaki A, Takahashi J
    Nutrients, 2021, Not reviewed
    13, 1814
  • Real-world effects and adverse events of romosozumab in Japanese osteoporotic patients: A prospective cohort study.
    Kobayakawa T, Suzuki T, Nakano M, Saito M, Miyazaki A, Takahashi J, Nakamura Y*
    Bone Rep, 2021, Not reviewed
    14, 101068
  • Reference values for bone metabolism in a Japanese cohort survey randomly sampled from a basic elderly resident registry.
    Tokida R, Uehara M, Nakano M, Suzuki T, Sakai N, Ikegami S, Takahashi J, Nakamura Y, Kato H
    Sci Rep, 2021, Not reviewed
    11, 7822
  • Pentosidine and carboxymethyl-lysine associate differently with prevalent osteoporotic vertebral fracture and various bone markers
    Nakano M, Nakamura Y*, Suzuki T, Miyazaki A, Takahashi J, Saito M, Shiraki M
    Sci Rep, 2020, Not reviewed
    10, 22090
  • Implications of historical height loss for prevalent vertebral fracture, spinal osteoarthritis, and gastroesophageal reflux disease
    Nakano M, Nakamura Y*, Suzuki T, Kobayashi T, Takahashi J, Shiraki M
    Sci Rep, 2020, Not reviewed
    10, 19036
  • Same-side insufficiency fractures of the tibia and femur after denosumab discontinuation: A case report
    Koiwai H, Kamimura M, Nakamura Y*, Takahashi J, Taguchi A
    Mod Rheumatol Case Rep, 2020, Not reviewed
    5, 178, 181
  • Spinal osteoarthritis is associated with stature loss independently of incident vertebral fracture in postmenopausal women.
    Nakano M, Nakamura Y*, Suzuki T, Takahashi J, Shiraki M
    Spine (Phila Pa 1976), 2020, Not reviewed
    45, E1400, E1404
  • Differences in bone mineral density and bone turnover markers between subjects with and without diffuse idiopathic skeletal hyperostosis.
    Uehara M, Takahashi J, Ikegami S, Tokida R, Nishimura H, Sakai N, Nakamura Y, Kato H
    Spine (Phila Pa 1976), 2020, Not reviewed
    45, E1677, E1681
  • The first experience of denosmab therapy on patients with Ehlers-Danlos syndrome and osteoporosis: Detailed observation of two patients.
    Yasukawa S, Uehara M, Suzuki T, Nakano M, Kosho T, Nakamura Y*, Takahashi J
    Mod Rheumatol Case Rep, 2020, Not reviewed
    44210
  • Remarkable loss of bone mineral density in 6 months after denosumab discontinuation: a case report
    Maezumi Y, Kamimura M, Nakamura Y*, Takahashi J
    Mod Rheumatol Case Rep, 2020, Not reviewed
    4, 218, 221
  • 骨粗鬆症対策. 特集 リウマチと整形外科
    中村幸男、鈴木孝子
    関節外科, 2020, Not reviewed
    39, 44, 49
  • スクレロスチン分泌低下に伴う大腿骨近位部骨折予防戦略
    中村幸男、鈴木孝子
    大和証券ヘルス財団研究業績集, 2020, Not reviewed
    43, 152, 154
  • Efficacy of denosumab therapy after alendronate treatment for a 66-year-old woman with Camurati-Engelmann disease and osteoporosis: A case report
    Uehara M, Nakamura Y*, Suzuki T, Takahashi J, Kato H
    Mod Rheumatol Case Rep, 2020, Not reviewed
    4, 131, 134
  • ZMAT2, a newly-identified potential disease-causing gene in congenital radioulnar synostosis, modulates BMP signaling
    Suzuki T, Nakano M, Komatsu M, Takahashi J, Kato H, Nakamura Y*
    Bone, 2020, Not reviewed
    136, 115349
  • Two adipocytokines, leptin and adiponectin, independently predict osteoporotic fracture risk at different bone sites in postmenopausal women
    Nakamura Y*, Nakano M, Suzuki T, Sato J, Kato H, Takahashi J, Shiraki M
    Bone, 2020, Not reviewed
    137, 115404
  • Efficacy of 4-year denosumab treatment alone or in combination with teriparatide in Japanese postmenopausal osteoporotic women
    Suzuki T, Nakamura Y*, Kato H
    Mod Rheumatol, 2019, Not reviewed
    29, 676, 681
  • Efficacy of denosumab therapy for osteoporosis-pseudoglioma syndrome with osteoporosis: A case report
    Miyazawa S, Nakamura Y*, Suzuki T, Kato H
    Mod Rheumatol Case Rep, 2019, Not reviewed
    3, 45, 48
  • The Shisa3 knockout mouse exhibits normal bone phenotype
    Murakami K, Zhifeng H, Suzuki T, Kobayashi Y, Nakamura Y*
    J Bone Miner Metab, 2019, Not reviewed
    37, 967, 975
  • Additive effects of eldecalcitol in poorly responding long-term bisphosphonate treatment for osteoporosis
    Kamimura M, Ikegami S, Mukaiyama K, Koiwai H, Nakamura Y*, Taguchi A, Kato H
    Osteoporos Sarcopenia, 2019, Not reviewed
    5, 57, 61
  • Effects of monthly minodronate with or without eldecalcitol addition in osteoporosis patients with rheumatoid arthritis: An 18-month prospective study
    Suzuki T, Nakamura Y*, Kato H
    Osteoporos Sarcopenia, 2019, Not reviewed
    5, 122, 127
  • Unexpected rapid increase in bone mineral density by bisphosphonate therapy after multiple spinal fractures: A case report
    Koiwai H, Kamimura M, Takahashi J, Nakamura Y*, Kato H
    J Med Case Rep, 2019, Not reviewed
    13, 288
  • Efficacy of denosumab therapy for a 21-year-old woman with Prader-Willi syndrome, osteoporosis and history of fractures: a case report
    Uehara M, Nakamura Y*, Takahashi J, Suzuki T, Iijima M, Arakawa Y, Ida K, Kosho T, Kato H
    Ther Clin Risk Manag, 2019, Not reviewed
    15, 303, 307, 10.2147/TCRM.S186855
  • 薬物療法による骨粗鬆症性骨折の予防と対策
    中村幸男
    日本骨粗鬆症学会雑誌, 2018, Not reviewed
    4, 188, 189
  • ステロイド性骨粗鬆症に対するdenosumabの有用性. 特集 ステロイド性骨粗鬆症のupdate
    中村幸男
    リウマチ科, 2018, Not reviewed
    60, 603, 608
  • Efficacy of teriparatide and denosumab combination treatment in a patient with atypical femoral fracture and Behçet's disease: A case report and review of the literature
    Uehara M, Nakamura Y*, Takahashi J, Isobe F, Ikegami S, Suzuki T, Uchiyama S, Kamimura M, Kato H
    Mod Rheumatol Case Rep, 2018, Not reviewed
    2, 92, 96
  • Novel method for evaluation of hindfoot alignment in weight-bearing position using laser beam
    Ohnishi T, Hida M, Nakamura Y*, Wada C
    J Phys Ther Sci, 2018, Not reviewed
    30, 474, 478
  • Denosumab significantly improves lumbar spine bone mineral density more in treatment-naïve than in long-term bisphosphonate-treated patients
    Suzuki T, Nakamura Y*, Kamimura M, Kato H
    Bone Rep, 2018, Not reviewed
    8, 110, 114
  • Efficacy of denosumab for glucocorticoid-induced osteoporosis in an adolescent patient with Duchenne muscular dystrophy. A case report
    Kumaki D, Nakamura Y*, Sakai N, Kosho T, Nakamura A, Hirabayashi S, Suzuki T, Kamimura M, Kato H
    JBJS Case Connect, 2018, Not reviewed
    8, e22
  • Determination of serum bone-related minerals during denosumab treatment in osteoporosis patients with rheumatoid arthritis
    Suzuki T, Nakamura Y*, Kato H
    Clin Nutr ESPEN, 2018, Not reviewed
    26, 53, 56
  • Efficacy, safety, and compliance of ibandronate treatment for 3 years in postmenopausal Japanese women with primary osteoporosis
    Suzuki T, Nakamura Y*, Kato H
    Osteoporos Sarcopenia, 2018, Not reviewed
    4, 69, 72
  • Efficacy of denosumab therapy for neurofibromatosis type I with osteoporosis and history of fractures: a case report
    Uehara M, Nakamura Y*, Takahashi J, Kamimura M, Isobe F, Yamaguchi T, Kosho T, Uchiyama S, Suzuki T, Kato H
    Ther Clin Risk Manag, 2018, Not reviewed
    14, 1243, 1246
  • Suppression of methotrexate-induced elevations in the serum alanine aminotransferase level of patients with rheumatoid arthritis who had prior hepatitis B infection
    Noguchi O, Nakamura Y, Kato H
    Health, 2018, Not reviewed
    10, 531, 541
  • Tofacitinib Versus Non-Tumor Necrosis Factor Biologics for Patients With Active Rheumatoid Arthritis
    Nakamura Y*, Suzuki T, Yamazaki H, Kato H
    Arch Rheumatol, 2018, Not reviewed
    33(2), 154, 159, 10.5606/ArchRheumatol.2018.6366
  • Olfactomedin-like protein OLFML1 inhibits Hippo signaling and mineralization in osteoblasts
    Murakami K, Kikugawa S, Kobayashi Y, Uehara S, Suzuki T, Kato H, Udagawa N, Nakamura Y*
    Biochem Biophys Res Commun, 2018, Not reviewed
    505(2), 419, 425, 10.1016/j.bbrc.2018.09.112
  • Efficacy and Safety of Denosumab Therapy for Osteogenesis Imperfecta Patients with Osteoporosis-Case Series
    Kobayashi T, Nakamura Y*, Suzuki T, Yamaguchi T, Takeda R, Takagi M, Hasegawa T, Kosho T, Kato H
    J Clin Med, 2018, Not reviewed
    7, E479, 10.3390/jcm7120479
  • Comparison of the effects of denosumab with either active vitamin D or native vitamin D on bone mineral density and bone turnover markers in postmenopausal osteoporosis
    Suzuki T, Nakamura Y*, Tanaka M, Kamimura M, Ikegami S, Uchiyama S, Kato H
    Mod Rheumatol, 2018, Not reviewed
    28(2), 376, 379, 10.1080/14397595.2017.1308454
  • Significant improvement of bone mineral density by denosumab treatment in Japanese osteoporotic patients following breast cancer treatment
    Nakamura Y*, Kamimura M, Morikawa A, Taguchi A, Suzuki T, Kato H
    Ther Clin Risk Manag, 2018, Not reviewed
    14, 543, 549, 10.2147/TCRM.S156466
  • Pretreatment of daily teriparatide enhances the increase of bone mineral density in cortical bones by denosumab therapy
    Kamimura M, Taguchi A, Nakamura Y*, Koiwai H, Ikegami S, Uchiyama S, Kato H
    Ther Clin Risk Manag, 2018, Not reviewed
    14, 637, 642, 10.2147/TCRM.S154686
  • Efficacy of denosumab in two cases with multiple-system atrophy and osteoporosis
    Uehara M, Nakamura Y*, Takahashi J, Suzuki T, Kato H
    Ther Clin Risk Manag, 2018, Not reviewed
    14, 817, 822, 10.2147/TCRM.S162574
  • Adequate nutrition status important for bone mineral density improvement in a patient with anorexia nervosa
    Nakamura Y*, Kamimura M, Koiwai H, Kato H
    Ther Clin Risk Manag, 2018, Not reviewed
    14, 945, 948, 10.2147/TCRM.S160280
  • Efficacy of Denosumab for Osteoporosis in Two Patients with Adult-Onset Still's Disease-Denosumab Efficacy in Osteoporotic Still's Disease Patients
    Kumaki D, Nakamura Y*, Suzuki T, Kato H
    J Clin Med, 2018, Not reviewed
    7(4), E63, 10.3390/jcm7040063
  • Significant improvement of bone mineral density by denosumab without bisphosphonate pre-treatment in glucocorticoid-induced osteoporosis.
    Suzuki T, Nakamura Y*, Kato H
    Mod Rheumatol, 2018, Not reviewed
    28, 885, 889
  • Effects of denosumab on osteoporosis in three cases with anorexia nervosa and a review of the literature.
    Isobe F, Nakamura Y*, Suzuki T, Kato H
    Mod Rheumatol Case Rep, 2018, Not reviewed
    2, 104, 106
  • Significant improvement of bone mineral density and bone turnover markers by denosumab therapy in bisphosphonate-unresponsive patients
    Kamimura M, Nakamura Y*, Ikegami S, Uchiyama S, Kato H, Taguchi A
    Osteoporos Int, 2017, Not reviewed
    28, 559, 566
  • Painful locking of the wrist in a patient with pseudoachondroplasia confirmed by COMP mutation
    Ideta H, Uchiyama S, Hayashi M, Kosho T, Nakamura Y, Kato H
    J Surg Case Rep, 2017, Not reviewed
    2017, rjw216
  • Comparison of effectiveness and safety of ibandronate and minodronate combined with eldecalcitol in primary osteoporosis of women: A 1-year follow-up study
    Tanaka M, Nakamura Y*, Itoh S, Kato Y
    Osteoporos Sarcopenia, 2017, Not reviewed
    3, 37, 44
  • Compliance and discontinuation of denosumab treatment in postmenopausal Japanese women with primary osteoporosis or rheumatoid arthritis and osteoporosis
    Suzuki T, Nakamura Y*, Kamimura M, Ikegami S, Uchiyama S, Kato H
    Osteoporos Sarcopenia, 2017, Not reviewed
    3, 108, 111
  • A Jak1/2 inhibitor, baricitinib, inhibits osteoclastogenesis by suppressing RANKL expression in osteoblasts in vitro
    Murakami K, Kobayashi Y, Uehara S, Suzuki T, Koide M, Yamashita T, Nakamura M, Takahashi N, Kato H, Udagawa N, Nakamura Y*
    PLoS One, 2017, Not reviewed
    12(7), e0181126, 10.1371/journal.pone.0181126
  • Changes of Bone-Related Minerals during Denosumab Administration in Post-Menopausal Osteoporotic Patients
    Suzuki T, Nakamura Y*, Kato H
    Nutrients, 2017, Not reviewed
    9(8), E871, 10.3390/nu9080871
  • Vitamin D and calcium are required at the time of denosumab administration during osteoporosis treatment
    Nakamura Y*, Suzuki T, Kamimura M, Ikegami S, Mukaiyama K, Uchiyama S, Taguchi A, Kato H
    Bone Res, 2017, Not reviewed
    5, 17021, 10.1038/boneres.2017.21
  • Bony findings detected by MRI may reflect the pathophysiology of osteoarthritis with thumb carpometacarpal joint pain
    Komatsu M, Kamimura M, Nakamura Y*, Mukaiyama K, Ikegami S, Hayashi M, Uchiyama S, Kato H
    Int J Rheum Dis, 2017, Not reviewed
    20, 1950, 1957, 10.1111/1756-185X.12781
  • Increased serum 25(OH)D3 levels in post-menopausal Japanese women with osteoporosis after 3-year bisphosphonate treatment
    Nakamura Y*, Uchiyama S, Kamimura M, Ikegami S, Komatsu M, Kato H
    Tohoku J Exp Med, 2017, Not reviewed
    242, 241, 246
  • Efficacy of denosumab for osteoporosis in three female patients with osteogenesis imperfecta
    Uehara M, Nakamura Y*, Takahashi J, Kamimura M, Ikegami S, Suzuki T, Uchiyama S, Yamaguchi T, Kosho T, Kato H
    Tohoku J Exp Med, 2017, Not reviewed
    242, 115, 120
  • Goniothalamin induces mitochondria-mediated apoptosis associated with endoplasmic reticulum stress-induced activation of JNK in HeLa cells
    Sophonnithiprasert T, Mahabusarakam W, Nakamura Y, Watanapokasin R
    Oncol Lett, 2017, Not reviewed
    13, 119, 128, 10.3892/ol.2016.5381
  • Short-term bisphosphonate treatment reduces serum 25(OH) vitamin D3 and alters values of parathyroid hormone, pentosidine, and bone metabolic markers
    Kamimura M, Uchiyama S, Nakamura Y*, Ikegami S, Mukaiyama K, Kato H
    Ther Clin Risk Manag, 2017, Not reviewed
    13, 161, 168, 10.2147/TCRM.S120749
  • Alfacalcidol Increases the Therapeutic Efficacy of Ibandronate on Bone Mineral Density in Japanese Women with Primary Osteoporosis
    Nakamura Y*, Suzuki T, Kamimura M, Ikegami S, Uchiyama S, Kato H
    Tohoku J Exp Med, 2017, Not reviewed
    241(4), 319, 326, 10.1620/tjem.241.319
  • Vitamin D and Calcium Are Required during Denosumab Treatment in Osteoporosis with Rheumatoid Arthritis
    Nakamura Y*, Suzuki T, Yoshida T, Yamazaki H, Kato H
    Nutrients, 2017, Not reviewed
    9(5), E428, 10.3390/nu9050428
  • Two-year clinical outcome of denosumab treatment alone and in combination with teriparatide in Japanese treatment-naive postmenopausal osteoporotic women
    Nakamura Y*, Suzuki T, Kamimura M, Ikegami S, Mukaiyama K, Uchiyama S, Taguchi A, Kato H
    Bone Res, 2017, Not reviewed
    5, 16055, 10.1038/boneres.2016.55
  • Value changes in bone turnover markers and bone mineral density using ibandronate in Japanese postmenopausal osteoporotic patients
    Nakamura Y*, Ikegami S, Takanashi Y, Kamimura M, Uchiyama S, Kato H
    J Nutr Disord Ther, 2016, Not reviewed
    6, 188
  • Effects of denosumab treatment during early pregnancy - A case report
    Isobe F, Nakamura Y*, Kamimura M, Uchiyama S, Kato H
    J Nutr Disord Ther, 2016, Not reviewed
    6, 189
  • Monthly minodronate inhibits bone resorption to a greater extent than does monthly risedronate
    Kamimura M, Nakamura Y*, Ikegami S, Komatsu M, Uchiyama S, Kato H
    Osteoporos Sarcopenia, 2016, Not reviewed
    2, 170, 174
  • Association of self-reported height loss and kyphosis with loss of teeth in Japanese elderly
    Taguchi A, Kamimura M, Sugino N, Uchida K, Kitamura Y, Ikegami S, Nakamura Y, Uchiyama S, Kato H
    Oral Health Dent Manag, 2016, Not reviewed
    15, 69, 74
  • 原発性骨粗鬆症に対する12カ月間のイバンドロネート注射製剤とエルデカルシトール併用治療の有効性と安全性の検討
    田中 瑞栄; 中村 幸男; 伊藤 聰一郎; 島本 周治; 加藤 義治
    日本骨粗鬆症学会雑誌 = The journal of Japan Osteoporosis Society, 2016, Not reviewed
    2(3), 275, 283
  • Risk factors of adjacent vertebral collapse after percutaneous vertebroplasty for osteoporotic vertebral fracture in postmenopausal women
    Takahara K, Kamimura M, Moriya H, Ashizawa R, Koike T, Hidai Y, Ikegami S, Nakamura Y*, Kato H
    BMC Musculoskelet Disord, 2016, Not reviewed
    17, 12, 10.1186/s12891-016-0887-0
  • Bone alterations are associated with ankle osteoarthritis joint pain
    Nakamura Y*, Uchiyama S, Kamimura M, Komatsu M, Ikegami S, Kato H
    Sci Rep, 2016, Not reviewed
    6, 18717, 10.1038/srep18717
  • Bisphosphonate pre-treatment diminishes the therapeutic benefits teriparatide in Japanese osteoporotic patients
    Kamimura M, Nakamura Y*, Ikegami S, Uchiyama S, Kato H
    Tohoku J Exp Med, 2016, Not reviewed
    239, 17, 24, 10.1620/tjem.239.17
  • The dynamin inhibitor dynasore inhibits bone resorption by rapidly disrupting actin rings of osteoclasts
    Thirukonda GJ, Uehara S, Nakayama T, Yamashita T, Nakamura Y, Mizoguchi T, Takahashi N, Yagami K, Udagawa N, Kobayashi Y
    J Bone Miner Metab, 2016, Not reviewed
    34, 395, 405, 10.1007/s00774-015-0683-1
  • Clinical implications of hip flexion in the measurement of spinal bone mineral density
    Ikegami S, Kamimura M, Uchiyama S, Nakamura Y, Mukaiyama K, Kato H
    J Clin Densitom, 2016, Not reviewed
    19, 270, 276, 10.1016/j.jocd.2015.11.002
  • Associations of self-reported height loss and kyphosis with vertebral fractures in Japanese women 60 years and older: a cross-sectional survey
    Kamimura M, Nakamura Y, Sugino N, Uchiyama S, Komatsu M, Ikegami S, Kato H, Taguchi A
    Sci Rep, 2016, Not reviewed
    6, 29199, 10.1038/srep29199
  • Delayed wound healing after tooth extraction and self-reported kyphosis in Japanese men and women
    Taguchi A, Kamimura M, Nakamura Y*, Sugino N, Ichinose A, Maezumi H, Fukuzawa K, Ashizawa R, Takahara K, Gushiken S, Mukaiyama K, Ikegami S, Uchiyama S, Kato H
    Sci Rep, 2016, Not reviewed
    6, 36309, 10.1038/srep36309
  • Bone alterations in painful osteoarthritic shoulder
    Komatsu M, Nakamura Y*, Kamimura M, Ikegami S, Mukaiyama K, Uchiyama S, Kato H
    J Case Rep, 2015, Not reviewed
    5, 84, 87
  • Goniothalamin enhances TRAIL-induced apoptosis in colorectal cancer cells through DR5 upregulation and cFLIP downregulation
    Sophonnithiprasert T, Nilwarangkoon S, Nakamura Y, Watanapokasin R
    Int J Oncol, 2015, Not reviewed
    47, 2188, 2196
  • Antiproliferation and apoptosis induction in colorectal cancer cells by goniothalamin
    Sophonnithiprasert T, Mahabusarakam W, Nakamura Y, Watanapokasin R
    J Med Assoc Thai, 2015, Not reviewed
    98(Suppl9), S146, 151
  • Changes in serum vitamin D and PTH values using denosumab with or without bisphosphonate pre-treatment in osteoporotic patients: A short-term study
    Nakamura Y*, Kamimura M, Ikegami S, Mukaiyama K, Uchiyama S, Taguchi A, Kato H
    BMC Endocr Disord, 2015, Not reviewed
    15, 81
  • Eldecalcitol, in combination with bisphosphonate, is effective for treatment of Japanese osteoporotic patients
    Mukaiyama K, Uchiyama S, Nakamura Y, Ikegami S, Taguchi A, Kamimura M, Kato H
    Tohoku J Exp Med, 2015, Not reviewed
    237, 339, 343
  • A case series of pregnancy- and lactation- associated osteoporosis and a review of the literature
    Nakamura Y*, Kamimura M, Ikegami S, Mukaiyama K, Komatsu M, Uchiyama S, Kato H
    Ther Clin Risk Manag, 2015, Not reviewed
    11, 1361, 1365
  • Wnt16 regulates osteoclast differentiation in conjunction with Wnt5a
    Kobayashi Y, Thirukonda GJ, Nakamura Y, Koide M, Yamashita T, Uehara S, Kato H, Udagawa N, Takahashi N
    Biochem Biophys Res Commun, 2015, Not reviewed
    463, 1278, 1283
  • Expression profiles of human CCN genes in patients with osteoarthritis or rheumatoid arthritis
    Komatsu M, Nakamura Y*, Maruyama M, Abe K, Watanapokasin R, Kato H
    J Orthop Sci, 2015, Not reviewed
    20, 708, 716
  • PCSK5 mutation in a patient with the VACTERL association
    Nakamura Y*, Kikugawa S, Seki S, Takahata M, Iwasaki N, Terai H, Matsubara M, Fujioka F, Inagaki H, Kobayashi T, Kimura T, Kurahashi H, Kato H
    BMC Res Notes, 2015, Not reviewed
    8, 228
  • Osteoarthritis in the forefoot accompanied with joint pain is potentially associated with bone alterations
    Nakamura Y*, Kamimura M, Uchiyama S, Komatsu M, Ikegami S, Kato H
    Int J Diagn Imaging, 2015, Not reviewed
    2, 64, 69
  • The skeletal muscle cross sectional area in long-term bisphosphonate users is smaller than that of bone mineral density-matched controls with increased serum pentosidine concentrations
    Uchiyama S, Ikegami S, Kamimura M, Mukaiyama K, Nakamura Y, Nonaka K, Kato H
    Bone, 2015, Not reviewed
    75, 84, 87
  • Elevation of serum alkaline phosphatase (ALP) level in postmenopausal women is caused by high bone turnover
    Mukaiyama K, Kamimura M, Uchiyama S, Ikegami S, Nakamura Y, Kato H
    Aging Clin Exp Res, 2015, Not reviewed
    27, 413, 418
  • Factors that characterize bone health with aging in healthy postmenopausal women
    Ikegami S, Uchiyama S, Nakamura Y, Mukaiyama K, Hirabayashi H, Kamimura M, Nonaka K, Kato H
    J Bone Miner Metab, 2015, Not reviewed
    33, 440, 447
  • Serum pentosidine levels after 3 years of bisphosphonate treatment in post-menopausal osteoporotic women
    Hashidate H, Kamimura M, Ikegami S, Mukaiyama K, Uchiyama S, Nakamura Y*, Kato H
    Endocr Res, 2015, Not reviewed
    40, 172, 176
  • ビスホスホネート製剤の長期使用の問題点と休薬(drug holiday)-非定型大腿骨骨折を念頭に. 特集 進化する骨粗鬆症診療
    内山茂晴、池上章太、中村幸男、加藤博之、三澤弘道
    リウマチ科, 2014, Not reviewed
    52, 567, 573
  • 骨代謝マーカーによる骨癒合評価
    上村幹男、中川浩之、池上章太、高原健治、外立裕之、中村幸男
    整形・災害外科, 2014, Not reviewed
    57, 629, 636
  • レーザー光を用いた距骨下関節アライメント計測法の開発
    大西忠輔、中村幸男、和田健征、井野秀一、佐藤満、肥田光正、山口浩史、小澤恵美、三沢貴博、和田親宗、加藤博之、本田哲三
    電子情報通信学会 信学技報, 2014, Not reviewed
    3, 61, 65
  • Knee joint pain potentially due to bone alterations in a knee osteoarthritis patient
    Komatsu M, Nakamura Y*, Kamimura M, Uchiyama S, Mukaiyama K, Ikegami S, Kato H
    Am J Case Rep, 2014, Not reviewed
    15, 534, 537
  • 原発性骨粗鬆症患者に対するミノドロン酸水和物とリセドロネートにおける早期の臨床効果(骨代謝マーカー)関する比較検討
    上村幹男、中村幸男
    オステオポローシス・ジャパン, 2014, Not reviewed
    22, 100, 101
  • 膝関節内ガングリオンと脂肪腫を合併した極めて稀な一例
    中村幸男、小林千益
    中部整災誌, 2014, Not reviewed
    57, 313, 314
  • Rapid bone destruction in a patient with knee osteoarthritis -A case report and review of the literature-
    Komatsu M, Kamimura M, Nakamura Y*, Mukaiyama K, Ikegami S, Uchiyama S, Kato H
    Clin Cases Miner Bone Metab, 2014, Not reviewed
    11, 239, 242
  • Temporal and Spatial Expression Patterns of Bone Morphogenetic Protein 3 in Developing Zebrafish
    Ito-Amano M, Nakamura Y*, Morisaki M, He X, Hayashi M, Watanapokasin R, Kato H
    Open Rheumatol J, 2014, Not reviewed
    8, 69, 72
  • The Pathophysiology and Progression of Hip Osteoarthritis Accompanied with Joint Pain are Potentially Due to Bone Alterations - Follow-up Study of Hip OA Patients
    Kamimura M, Nakamura Y*, Uchiyama S, Ikegami S, Mukaiyama K, Kato H
    Open Rheumatol J, 2014, Not reviewed
    8, 46, 53
  • Case with Atypical Clinical Course Diagnosed as Osteoarthritis, Osteonecrosis, Subchondral Insufficiency Fracture, or Rapidly Destructive Coxopathy
    Nakamura Y*, Kamimura M, Mukaiyama K, Ikegami S, Uchiyama S, Kato H
    Open Rheumatol J, 2014, Not reviewed
    8, 20, 23
  • Changes in Bone Turnover Markers and Fracture in Osteo¬porosis: A Review of the Literature
    Nakamura Y*, Kamimura M, Ikegami S, Mukaiyama K, Uchiyama S, Kato H
    Ann Orthop Rheumatol, 2014, Not reviewed
    2, 1023
  • Tramadol/acetaminophen causes constipation more frequently in women with degenerative spinal disorders than in those with degenerative joint disorders
    Kamimura M, Nakamura Y*, Ikegami S, Ichinose A, Uchiyama S, Kato H
    Drugs Ther Perspect, 2014, Not reviewed
    30, 149, 154
  • Significant differences of brain blood flow in patients with chronic low back pain and acute low back pain detected by brain SPECT
    Nakamura Y, Nojiri K, Yoshihara H, Takahata T, Honda-Takahashi K, Kubo S, Sakatsume K, Kato H, Maruta T, Honda T
    JOURNAL OF ORTHOPAEDIC SCIENCE, 2014, Not reviewed
    19(3), 384, 389, 10.1007/s00776-014-0534-2
  • 小児新鮮Monteggia骨折で橈骨頭観血的整復を要した6例の病態と手術成績
    渡邉佳洋、保坂正人、中村幸男、伊坪敏郎、内山茂晴、加藤博之
    日本肘関節学会誌, 2013, Not reviewed
    20, 142, 145
  • 進行性偽性リウマチ様異形成と変形性関節症の病態検討
    中村幸男、多田秀穂、Ramida Watanapokasin、加藤博之
    臨床雑誌整形外科, 2013, Not reviewed
    64, 50
  • The Pathophysiology of Primary Hip Osteoarthritis may Originate from Bone Alterations
    Kamimura M, Nakamura Y*, Ikegami S, Mukaiyama K, Uchiyama S, Kato H
    Open Rheumatol J, 2013, Not reviewed
    7, 112, 118
  • Joint pain undergoes a transition in accordance with signal changes of bones detected by MRI in hip osteoarthritis
    Kamimura M, Nakamura Y*, Uchiyama S, Ikegami S, Kato H
    Open Rheumatol J, 2013, Not reviewed
    7, 67, 74
  • let-7 and miR-140 microRNAs coordinately regulate skeletal development
    Papaioannou G, Inloes J, Nakamura Y, Paltrinieri E, Kobayashi T
    Proc Natl Acad Sci U S A, 2013, Not reviewed
    110, E3291, 3300, 10.1073/pnas.1302797110
  • Apoptotic Induction of Skin Cancer Cell Death by Plant Extracts
    Thuncharoen W, Chulasiri M, Nilwarangkoon S, Nakamura Y, Watanapokasin R
    J Med Assoc Thai, 2013, Not reviewed
    96(Suppl 1), S60, 64
  • 軟骨特異的に発現するmiRNA140は内軟骨性骨化に重要でありBMPシグナルを制御するDnpepを標的とする
    中村幸男、片桐岳信、加藤博之、小林竜也
    中部整災誌, 2012, Not reviewed
    55, 571, 572
  • 受傷4日後に後骨間神経麻痺が明らかになった小児Monteggia骨折の1例
    中村幸男、多田秀穂、中村恒一、加藤博之
    日本肘関節学会誌, 2012, Not reviewed
    19, 256, 258
  • microRNA140とそのホスト遺伝子であるWwp2は口蓋軟骨発生・形成に重要である
    中村幸男、秋山治彦、多田秀穂、Ramida Watanapokasin、脇谷滋之、加藤博之
    臨床雑誌整形外科, 2012, Not reviewed
    63, 1286, 1287
  • 進行性偽性リウマチ様異形成の原因と診断
    中村幸男、加藤博之
    臨床雑誌整形外科, 2012, Not reviewed
    63, 1362
  • 慢性痛のリハビリテーション
    本田哲三、本田玖美子、高橋理夏、中村幸男、大房幸浩
    ペインクリニック, 2012, Not reviewed
    33, 1683, 1690
  • Sox9 is upstream of microRNA-140 in cartilage
    Nakamura Y, He X, Kato H, Wakitani S, Kobayashi T, Watanabe S, Iida A, Tahara H, Warman ML, Watanapokasin R, Postlethwait JH
    Appl Biochem Biotechnol, 2012, Not reviewed
    166, 64, 71
  • Identification and functional analysis of Zranb2 as a novel Smad-binding protein that suppresses BMP signaling
    Ohte S, Kokabu S, Iemura SI, Sasanuma H, Yoneyama K, Shin M, Suzuki S, Fukuda T, Nakamura Y, Jimi E, Natsume T, Katagiri T
    J Cell Biochem, 2012, Not reviewed
    113, 808, 814
  • Histone deacetylase-4 is required during early cranial neural crest development for generation of the zebrafish palatal skeleton
    Delaurier A, Nakamura Y, Braasch I, Khanna V, Kato H, Wakitani S, Postlethwait JH, Kimmel CB
    BMC Dev Biol, 2012, Not reviewed
    12, 16
  • Craniofacial abnormalities result from knock down of nonsyndromic clefting gene, crispld2, in zebrafish
    Yan Q, Chiquet BT, DeVault L, Warman ML, Nakamura Y, Swindell EC, Hecht JT
    Genesis, 2012, Not reviewed
    50, 871, 881
  • 進行性偽性リウマチ様異形成の原因遺伝子であるWISP3の役割解明に向けた動物モデルアプローチ
    中村幸男、脇谷滋之、田原秀晃、加藤博之、Matthew L. Warman
    日本小児整形外科学会雑誌, 2011, Not reviewed
    20, 1, 5
  • Wwp2 is essential for palatogenesis mediated by the interaction between Sox9 and mediator subunit 25
    Nakamura Y, Yamamoto K, He X, Otsuki B, Kim Y, Murao H, Soeda T, Tsumaki N, Deng JM, Zhang Z, Behringer RR, Crombrugghe BD, Postlethwait JH, Warman ML, Nakamura T, Akiyama H
    Nat Commun, 2011, Not reviewed
    2, 251
  • α-Mangostin induces apoptosis in human chondrosarcoma cells through downregulation of ERK/JNK and Akt signaling pathway
    Krajarng A, Nakamura Y, Suksamrarn S, Watanapokasin R
    J Agric Food Chem, 2011, Not reviewed
    59, 5746, 5754
  • Effects of α-mangostin on apoptosis induction of human colon cancer
    Watanapokasin R, Jarinthanan F, Nakamura Y, Sawasjirakij N, Jaratrungtawee A, Suksamrarn S
    World J Gastroenterol, 2011, Not reviewed
    17, 2086, 2095
  • Chondrocyte-specific microRNA-140 regulates endochondral bone development and targets Dnpep to modulate bone morphogenetic protein signaling
    Nakamura Y, Inloes J, Katagiri T, Kobayashi T
    Mol Cell Biol, 2011, Not reviewed
    31, 3019, 3028
  • 整形トピックス ゼブラフィッシュと整形外科分野
    中村幸男
    臨床雑誌整形外科, 2010, Not reviewed
    61, 454
  • Zebrafish models for human FKRP muscular dystrophies
    Kawahara G, Guyon JR, Nakamura Y, Kunkel LM
    Hum Mol Genet, 2010, Not reviewed
    19, 623, 633
  • Potential of xanthones from tropical fruit mangosteen as anti-cancer agents: Caspase-dependent apoptosis induction in vitro and in mice
    Watanapokasin R, Jarinthanan F, Jerusalmi A, Suksamrarn S, Nakamura Y, Sukseree S, Uthaisang-Tanethpongtamb W, Ratananukul P, Sano T
    Appl Biochem Biotechnol, 2010, Not reviewed
    162, 1080, 1094
  • Temporal and spatial expression of CCN genes in zebrafish
    Fernando CA, Conrad PA, Bartels CF, Marques T, To M, Balow SA, Nakamura Y*, Warman ML
    Dev Dyn, 2010, Not reviewed
    239, 1755, 1767
  • Normal growth and development in mice over-expressing the CCN family member WISP3
    Nakamura Y*, Cui Y, Fernando C, Kutz WE, Warman ML
    J Cell Commun Signal, 2009, Not reviewed
    3, 105, 113
  • Wif-1 is expressed at cartilage-mesenchyme interfaces and impedes Wnt3a-mediated inhibition of chondrogenesis
    Surmann-Schmitt C, Widmann N, Dietz U, Saeger B, Eitzinger N, Nakamura Y, Rattel M, Latham R, Hartmann C, von der Mark H, Schett G, von der Mark K, Stock M
    J Cell Sci, 2009, Not reviewed
    122, 3627, 3637
  • Unique roles of microRNA140 and its host gene WWP2 in cartilage biology
    Nakamura Y, He X, Kobayashi T, Yan YL, Postlethwait JH, Warman ML
    J Musculoskelet Neuronal Interact, 2008, Not reviewed
    8, 321, 322
  • The CCN family member Wisp3, mutant in progressive pseudo rheumatoid dysplasia, modulates BMP and Wnt signaling
    Nakamura Y, Weidinger G, Liang JO, Aquilina-Beck A, Tamai K, Moon RT, Warman ML
    J Clin Invest, 2007, Not reviewed
    117, 3075, 3086
  • Coordinate expression of BMP-2, BMP receptors and Noggin in normal mouse spine
    Nakamura Y, Nakaya H, Saito N, Wakitani S
    J Clin Neurosci, 2006, Not reviewed
    13, 250, 256
  • Use of bone morphogenetic protein 2 and diffusion chambers to engineer cartilage tissue for the repair of defects in articular cartilage
    Nawata M, Wakitani S, Nakaya H, Tanigami A, Seki T, Nakamura Y, Saito N, Sano K, Hidaka E, Takaoka K
    Arthritis Rheum, 2005, Not reviewed
    52, 155, 163
  • Meningioma arising in Werner syndrome confirmed by mutation analysis
    Nakamura Y*, Shimizu T, Ohigashi Y, Itou N, Ishikawa Y
    J Clin Neurosci, 2005, Not reviewed
    12, 503, 506
  • Expression profiles and functional analyses of Wnt-related genes in human joint disorders
    Nakamura Y, Nawata M, Wakitani S
    Am J Pathol, 2005, Not reviewed
    167, 97, 105
  • Microbubble-enhanced ultrasound exposure promotes uptake of methotrexate into synovial cells and enhanced antiinflammatory effects in the knees of rabbits with antigen-induced arthritis
    Nakaya H, Shimizu T, Isobe K, Tensho K, Okabe T, Nakamura Y, Nawata M, Yoshikawa H, Takaoka K, Wakitani S
    Arthritis Rheum, 2005, Not reviewed
    52, 2559, 2566
  • The effects of heat on the biological activity of recombinant human bone morphogenetic protein-2
    Ohta H, Wakitani S, Tensho K, Horiuchi H, Wakabayashi S, Saito N, Nakamura Y, Nozaki K, Imai Y, Takaoka K
    J Bone Miner Metab, 2005, Not reviewed
    23, 420, 425
  • Expression profiles of BMP-related molecules induced by BMP-2 or -4 in muscle-derived primary culture cells
    Nakamura Y, Wakitani S, Saito N, Takaoka K
    J Bone Miner Metab, 2005, Not reviewed
    23, 426, 434
  • Embryonic stem cells form articular cartilage, not teratomas, in osteochondral defects of rat joints
    Wakitani S, Aoki H, Harada Y, Sonobe M, Morita Y, Mu Y, Tomita N, Nakamura Y, Takeda S, Watanabe TK, Tanigami A
    Cell Transplant, 2004, Not reviewed
    13, 331, 336
  • Autologous bone marrow stromal cell transplantation for repair of full-thickness articular cartilage defects in human patellae: Two case reports
    Wakitani S, Mitsuoka T, Nakamura N, Toritsuka Y, Nakamura Y, Horibe S
    Cell Transplant, 2004, Not reviewed
    13, 595, 600
  • 関節軟骨の再生. 特集 現代医療の最前線(前篇)-再生医療と細胞療法-
    脇谷滋之、中谷宏幸、中村幸男、縄田昌司
    最新医学, 2003, Not reviewed
    58, 261, 268
  • 自己骨髄間葉系細胞移植による関節軟骨修復
    中谷宏幸、脇谷滋之、縄田昌司、中村幸男
    関節外科, 2003, Not reviewed
    22, 63, 66
  • 骨髄間葉系細胞移植による修復
    脇谷滋之、縄田昌司、中村幸男、中谷宏幸
    整形・災害外科, 2003, Not reviewed
    46, 141, 146
  • Multiple periarticular osteosclerosis accompanied by joint destruction treated with bilateral total knee arthroplasty
    Nakamura Y*, Nomura T, Nakajima S, Ito N, Wakitani S
    J Arthroplasty, 2003, Not reviewed
    18, 100, 104
  • Triple primary sarcoma in Werner syndrome with a novel mutation
    Nakamura Y*, Shimizu T, Ishikawa Y, Matsumoto T, Sugimoto M, Goto M, Yoshimura Y, Wakitani S, Takaoka K
    Rheumatology, 2003, Not reviewed
    42, 1, 2
  • Temporal and spatial expression profiles of BMP receptors and Noggin during BMP-2 induced ectopic bone formation
    Nakamura Y, Wakitani S, Nakayama J, Wakabayashi S, Horiuchi H, Takaoka K
    J Bone Miner Res, 2003, Not reviewed
    18, 1854, 1862
  • 80歳以上の変形性股関節症に対する人工関節置換術 -機種の選択とソケット設置角-
    野村隆洋、大久保守、百瀬敏充、中村幸男、倉石修吾、荻原伸英
    臨床雑誌整形外科, 2001, Not reviewed
    52, 649, 651
  • セメントレス人工膝関節全置換術の出血対策 -無輸血手術の工夫-
    中村幸男、野村隆洋、大久保守、倉石修吾、荻原伸英
    臨床雑誌整形外科, 2001, Not reviewed
    52, 1133, 1134
  • 高齢者の股関節症とその発症および進行因子としての腰椎後弯
    野村隆洋、大久保守、百瀬敏充、中村幸男、倉石修吾、荻原伸英
    臨床雑誌整形外科, 2001, Not reviewed
    52, 1585, 1588
  • 飯田市立病院における人工膝関節置換術の成績と現況
    中村幸男、野村隆洋、大久保守、倉石修吾、荻原伸英
    長野県医学会雑誌, 2001, Not reviewed
    32, 7
  • 急速破壊型股関節症を早期に診断するための臨床的指標
    野村隆洋、大久保守、安達徹、中村幸男
    臨床雑誌整形外科, 2000, Not reviewed
    51, 403, 406
  • 改良手技によるCharnley人工股関節10-16年経過例の成績 -オートロン90の摩耗計測とその限界
    野村隆洋、大久保守、安達徹、中村幸男
    臨床雑誌整形外科, 2000, Not reviewed
    51, 1625, 1628
  • Extradigital glomus tumor causing para-Achilles tendon pain. -A case report-
    Nakamura Y*, Nomura T, Ookubo M, Adati T, Harada D
    Acta Orthop Belg, 2000, Not reviewed
    66, 503, 506
  • 複数病変を有する脊椎疾患の高位診断に磁気刺激検査が有効であった2例
    中村幸男、江原宗平、上村幹夫、立岩裕、木下哲也、伊藤秀博、湯沢洋平、三沢朋子、高岡邦夫
    東海脊椎外科, 1999, Not reviewed
    13, 62, 63
  • 原発性全身性アミロイド-シスを合併した慢性関節リウマチの1例
    鳥海宏、宮坂忠篤、内山茂晴、中川浩之、中村幸男
    骨粗鬆症・骨折研究会報, 1999, Not reviewed
    6, 635, 636
  • Longitudinal median nerve conduction studies after endoscopic carpal tunnel release
    Nakamura Y, Uchiyama S, Toriumi H, Nakagawa H, Miyasaka T
    Hand Surg, 1999, Not reviewed
    4, 145, 149
  • 大腿部に発生した嚢胞状リンパ管腫の1例
    中村幸男、清水富永、吉村康夫、高岡邦夫
    臨床雑誌整形外科, 1998, Not reviewed
    49, 1124, 1127
  • 骨軟骨腫に似た画像所見を呈した脛骨腱靭帯付着部症の1例
    中村幸男、清水富永、吉村康夫、赤羽努、高岡邦夫
    臨床雑誌整形外科, 1998, Not reviewed
    49, 1646, 1647

MISC

  • 骨粗鬆症と関節リウマチの治療ストラトジー
    中村幸男
    大津市医師会誌, 2019
    42, 13, 13
  • 骨粗鬆症対策
    中村幸男、鈴木孝子
    宇摩医師会報, 2019
    155, 5, 5
  • 骨粗しょう症と、寝たきりリスクを回避する「かかと落とし」で骨密度を上げる!
    中村幸男
    壮快, 2018
    (10), 100, 101
  • 骨粗鬆症のトータルケア
    中村幸男
    一個人, 2018
    (11), 40, 45
  • 末梢神経障害の定量的評価のための足底感覚計測システムに関する基礎研究
    井野秀一、高橋紀代、佐藤満、吉村真一、大西忠輔、中村幸男、本田哲三
    第25回バイオエンジニアリング講演会論文集, 2013
    48, 497, 498
  • 高齢でも骨密度が大幅にアップすると判明!かかと落としはリウマチの骨にも有効
    中村幸男
    日本機械学会2013年度年次大会講演論文集, 2013
    J151025, 1, 4
  • 立位時の足底面に対するせん断応力の感覚閾値と圧分布パターンの足底
    大西忠輔、佐藤満、中村幸男、本田哲三、高橋紀代、吉村真一、井野秀一
    日整会誌, 2005
    79, 292, 292
  • ラット胎児骨格筋由来間葉系細胞からの異所性軟骨誘導
    縄田昌司、脇谷滋之、中村幸男、中谷宏幸、大島和也、高岡邦夫
    日整会誌, 2003
    77, 937, 937
  • 成長因子による関節軟骨欠損修復
    脇谷滋之、中村幸男、天正恵治、岡部高弘、中谷宏幸
    日整会誌, 2003
    77, 988, 988
  • 多変量解析を用いた、ソケットの摩耗促進因子の検討 -危険因子と摩耗量の予測-
    野村隆洋、大久保守、中村幸男、倉石修吾、荻原伸英
    日整会誌, 2001
    75, 46, 46
  • 特発性急性脊髄硬膜外血腫の1例
    倉石修吾、安達徹、大久保守、野村隆洋、中村幸男、荻原伸英
    日整会誌, 2001
    75, 449, 449
  • 大腿骨頸部insufficiency fractureの頻度と早期診断
    倉石修吾、野村隆洋、大久保守、百瀬敏充、中村幸男、荻原伸英
    信州医誌, 2001
    49, 52, 52
  • 広範囲腰背部皮下膿瘍の2例
    荻原伸英、野村隆洋、大久保守、百瀬敏充、中村幸男、倉石修吾
    信州医誌, 2001
    49, 178, 178
  • 異所性骨形成の過程におけるBMPレセプターとNogginの発現プロファイル
    中村幸男、脇谷滋之、中山淳、若林真司、堀内博、縄田昌司、中谷宏幸、高岡邦夫
    信州医誌, 2001
    49, 179, 179
  • 両膝関節の異常な骨硬化像と骨破壊を生じ、人工関節を行った透析患者の1例
    中村幸男、野村隆洋、大久保守、安達徹
    日整会誌, 2000
    74, 96, 96
  • セメントレス人工膝関節全置換術の出血対策 -無輸血手術の工夫-
    中村幸男、野村隆洋、大久保守、倉石修吾、荻原伸英
    信州医誌, 2000
    48, 295, 295
  • 改良手技によるCharnley人工股関節10-16年経過例の成績 -オートロン90の摩耗計測とその限界-
    野村隆洋、大久保守、中村幸男、安達徹
    信州医誌, 1999
    48, 148, 148

Books and other publications

  • 本当に必要な「ゆるスクワット」と「かかと落とし」
    中村幸男
    台湾・時報文化 出版公司, 2021
  • 産後圧迫骨折, 膠原病・リウマチ疾患と妊娠・授乳ハンドブック
    中村幸男
    南山堂, 2019
    73-78
  • 本当に必要な「ゆるスクワット」と「かかと落とし」
    中村幸男
    小学館, 2018

Lectures, oral presentations, etc.

  • 関節リウマチ診療における骨粗鬆症の重要性
    中村幸男
    第35回日本臨床リウマチ学会スポンサードlivewebセミナー7 WEB開催 ランチョンセミナー, 2020
  • 長野コホートスタディで行われた骨粗鬆症、フレイル、生活習慣病に関する研究
    浦野友彦、白木正孝、中村幸男、今井 匠、齊藤充
    第22回日本骨粗鬆症学会, 2020
  • ラットにおける亜鉛欠乏食投与による骨代謝への影響
    鈴木孝子、松崎広志、中村幸男、鈴木和春
    第22回日本骨粗鬆症学会, 2020
  • 原発性骨粗鬆症患者におけるビタミンD製剤の有無に伴うイバンドロネート経口剤の治療成績
    鈴木孝子、中村幸男 、中野真樹、髙橋淳
    第22回日本骨粗鬆症学会, 2020
  • 既存椎体骨折・変形性脊椎症・胃食道逆流症に対する身長低下の関連とカットオフ値
    中野真樹、中村幸男 、鈴木孝子、髙橋淳、白木正孝
    第22回日本骨粗鬆症学会, 2020
  • 閉経後女性において血中アディポサイトカイン濃度は独立した骨折の予測因子である
    中村幸男 、中野真樹、鈴木孝子、髙橋淳、白木正孝
    第22回日本骨粗鬆症学会, 2020
  • 骨粗鬆症とミネラル動態
    中村幸男
    第62回日本老年医学会学術集会 アフタヌーンセミナー1, 2020
  • ロモソズマブ使用後の骨密度と骨代謝マーカーの変化について
    小早川知範、鈴木孝子、岡本佳子、源馬昌代、武藤美千代、小早川雅洋、高橋淳、中村幸男
    第93回日本整形外科学会学術総会-オンライン学術総会-, 2020
  • 関節リウマチのトータルマネジメント-JAK阻害薬の最新の知見を含めて-
    中村幸男
    第93回日本整形外科学会学術総会ランチョンセミナー6, 2020
  • 長野県内における市民公開講座を通してのリウマチ医療広報活動報告
    山﨑秀、金物壽久、浦野房三、鈴木貞博、松田正之、林 真利、石井 亘、下島恭弘、中村幸男
    第70回日本病院学会, 2020
  • 関節リウマチの病態、診断、治療の実際
    中村幸男
    長野県診療放射線技師学術大会ランチョンセミナー, 2019
  • 骨粗鬆症の薬物治療 骨粗鬆症脆弱性骨折の現状と対策:百寿への取り組み
    中村幸男
    第6回サルコペニア・フレイル学会 -シンポジウム4-, 2019
  • 閉経後骨粗鬆症患者においてビタミンD使用有無における短期ゾレドロネート使用成績
    中村幸男、鈴木孝子、加藤博之
    第21回日本骨粗鬆症学会, 2019
  • 実臨床に基づいた骨粗鬆症治療戦略
    中村幸男
    第33回日本整形外科学会基礎学術集会, 2018
  • ランチョンセミナー 骨粗鬆症と脆弱性骨折予防戦略~長野県内の取り組みとリエゾンサービスの重要性~
    中村幸男
    第131回中部日本整形外科災害外科学会・学術集会, 2018
  • 骨粗鬆症の最近の動向と今後の展望
    中村幸男
    第32回日本臨床内科医学会 モーニングセミナー, 2018
  • JAK阻害薬は骨芽細胞のRANKL発現を抑制し、破骨細胞の分化を阻害する
    中村幸男、村上康平、鈴木孝子、加藤博之、小林泰浩
    第91回日本整形外科学会学術総会, 2018
  • 信州リウマチネットワークの10 年と次世代への継承を目指したこれからの10 年:RAにおける地域連携の取り組みと工夫
    山崎秀、中村幸男、下島恭弘、林真利、石井亘、松田正之、加藤博之、鈴木貞博、浦野房三、金物壽久
    第91回日本整形外科学会学術総会, 2018
  • 活動性関節リウマチ患者においてトファシチニブはnon TNF阻害剤と同等の安全性、有効性を示す
    中村幸男、山崎秀、鈴木孝子、加藤博之
    第62回日本リウマチ学会総会・学術集会, 2018
  • Compliance, Adverse Effects, Bone-related Mineral and Vitamin D Status, and Literature Review of Denosumab Therapy for Osteoporosis in Japan
    Nakamura Y, Suzuki T, Kato H
    ASBMR 2018 Annual Meeting in MO, Canada, 2018
  • Identification and Molecular Analysis of a Potential Disease-Causing Mutation in ZMAT2 in Congenital Radioulnar Synostosis
    Suzuki T, Nakamura Y, Kobayashi T, Kato H
    ASBMR 2018 Annual Meeting in MO, Canada, 2018
  • 骨代謝マーカーの最近の話題-骨代謝マーカーについて学ぶ
    中村幸男
    第19回日本骨粗鬆症学会, 2017
  • ビスホスホネート長期投与例にエルデカルシトールを追加投与すると骨密度は上昇する
    小岩井秀史、上村幹男、向山啓二郎、中村幸男、池上章太、内山茂晴、加藤博之
    第19回日本骨粗鬆症学会, 2017
  • 短期間のビスホスホネートの投与によって血中ビタミンDの濃度は低下する
    向山啓二郎、上村幹男、内山茂晴、中村幸男、池上章太、加藤博之
    第19回日本骨粗鬆症学会, 2017
  • 閉経後骨粗鬆症患者に対し、天然型D・エルデカルシドール併用の違いによる12か月間のデノスマブ投与後の骨代謝、骨密度評価
    鈴木孝子、中村幸男、上村幹男、池上章太、内山茂晴、加藤博之
    第19回日本骨粗鬆症学会, 2017
  • 活性型ビタミンD併用によるイバンドロネート投与18か月間の効果についての検証
    中村幸男、鈴木孝子、上村幹男、池上章太、内山茂晴、加藤博之
    第19回日本骨粗鬆症学会, 2017
  • 原発性骨粗鬆症に対するデノスマブによる治療には天然型ビタミンDおよびカルシウム剤の併用が必要である
    中村幸男、鈴木孝子、上村幹男、池上章太、内山茂晴、加藤博之
    第19回日本骨粗鬆症学会, 2017
  • 閉経後骨粗鬆症患者においてデノスマブ及びテリパラチド併用療法とデノスマブ単独療法による24か月間の骨代謝マーカー、骨密度の評価
    中村幸男、鈴木孝子、上村幹男、池上章太、内山茂晴、田口明、加藤博之
    第19回日本骨粗鬆症学会, 2017
  • 閉経後骨粗鬆症患者に対しビスホスホネート単剤使用による3年間の天然型ビタミンD変化の検討
    中村幸男、上村幹男、池上章太、内山茂晴、加藤博之
    第19回日本骨粗鬆症学会, 2017
  • デノスマブは関節リウマチ骨粗鬆症患者のビスフォスフォネート製剤効果不十分例に有効か
    山﨑秀、高梨哲生、中村幸男
    第29回中部リウマチ学会, 2017
  • 小児骨粗鬆症治療の現状と課題
    中村幸男、上原将志、高橋淳、鈴木孝子、熊木大輝、磯部文洋、池上章太、古庄知己、上村幹男、内山茂晴、加藤博之
    第120回信州整形外科懇談会, 2017
  • JAK1/2阻害薬baricitinibは骨芽細胞のRANKL発現を抑制することで破骨細胞の分化を阻害する
    村上康平、小林泰浩、上原俊介、鈴木孝子、宇田川信之、高橋直之、加藤博之、中村幸男
    第35回日本骨代謝学会学術集会, 2017
  • 閉経後骨粗鬆症患者において、デノスマブとテリパラチド併用療法はデノスマブ単独療法よりも有効か?~2年経過を踏まえて~
    中村幸男、加藤博之
    第61回日本リウマチ学会総会・学術集会, 2017
  • ラットにおける飼料中亜鉛量の違いによる組織中ミネラル分布
    鈴木孝子、勝間田真、松﨑広志、中村幸男、鈴木和春
    第27回微量元素学会, 2016
  • 関節炎によるSfrp5の発現低下は、Wnt5aによる骨吸収を亢進させる
    中村幸男、前田和洋、加藤博之、宇田川信之、高橋直之、小林泰浩
    第34回日本骨代謝学会学術集会, 2016
  • 健康長寿向上に向けた骨対策
    中村幸男、上村幹男、向山啓二郎、池上章太、内山茂晴、加藤博之
    第34回日本骨代謝学会学術集会, 2016
  • ビスホスホネート薬前投与有無がテリパラチド製剤投与に伴う骨代謝マーカーおよび骨密度に与える影響の検討
    中村幸男、上村幹男、向山啓二郎、池上章太、内山茂晴、加藤博之
    第89回日本整形外科学会総会, 2016
  • 変形性股関節症における疼痛発生機序に骨の役割は重要である
    中村幸男、加藤博之
    第59回日本リウマチ学会総会・学術集会, 2015
  • Identification of a novel PCSK5 frameshift mutation in a patient with the VACTERL association
    Nakamura Y, Kikugawa S, Seki S, Takahata M, Iwasaki N, Terai H, Matsubara M, Fujioka F, Inagaki H, Kobayashi T, Kimura T, Kurahashi H, Kato H
    ASBMR 2014 Annual Meeting, Houston, TX, USA, 2014
  • The roles of miR-140 and Wwp2 in skeletal development
    Nakamura Y
    AIMM/ASBMR John Haddad Young Investigators' Meeting. Snowmass, CO, USA, 2012, Invited
  • The roles of microRNA140 during endochondral bone development
    Nakamura Y
    5th Medical Biotech Forum. Beijing, China, 2011, Invited
  • Model organism approaches to understand the role of WISP3, the gene that is mutated in Progressive Pseudorheumatoid Dysplasia
    Nakamura Y
    A Seminar at Endocrine Division. Massachusetts General Hospital. Boston, MA, USA, 2008, Invited
  • Model organism approaches to understand the role of WISP3, the gene that is mutated in Progressive Pseudorheumatoid Dysplasia
    Nakamura Y
    A Seminar at Department of Orthopaedic Surgery. University of California. Davis, CA, USA, 2008, Invited
  • Deciphering the roles of Wisp3 in cartilage using model organism approaches
    Nakamura Y
    A Seminar at Matsumoto Dental University. Nagano, Japan, 2008, Invited
  • The role of microRNA140 during cartilage development
    Nakamura Y
    Sun Valley Workshop on Skeletal Tissue Biology. Sun Valley, ID, USA, 2008, Invited
  • Wnt-1 inducible signaling protein 3 (WISP3) can modulate BMP and Wnt signaling
    Nakamura Y
    Gordon Research Conference. Cartilage Biology & Pathology. Ventura, CA, USA, 2007, Invited
  • Using zebrafish to identify biologic activities for WISP3, the gene that is mutated in Progressive Pseudorheumatoid Dysplasia
    Nakamura Y
    RA Interface Rounds. Brigham & Women's Hospital. Boston, MA, USA, 2007, Invited
  • Zebrafish studies of cartilage biology
    Nakamura Y
    21st Annual David Grice Lecture. Children's Hospital Boston. Boston, MA, USA, 2007, Invited
  • Model organism approaches toward identifying the role of Wisp3 in cartilage
    Warman ML, Nakamura Y
    19th Annual Meeting of the Japanese Society of Cartilage Metabolism. Yokohama, Japan, 2006, Invited
  • Deciphering the function of Wnt1-inducible signaling protein 3 (WISP3) in cartilage
    Warman ML, Nakamura Y
    Developmental Biology in Orthopaedics. American Academy of Orthopaedic Surgeons 2006. Research Symposium. Toronto, Canada, 2006, Invited
  • Temporal and spatial expression profiles of BMP receptors and Noggin during BMP-2 induced ectopic bone formation
    Nakamura Y, Wakitani S, Nakayama J, Wakabayashi S, Horiuchi H, Takaoka K
    1st Joint Meeting of International Bone and Mineral Society-Japanese Society for Bone and Mineral Research. Osaka, Japan, 2003, Invited

Research Themes

  • 骨粗鬆症、骨折予防に最適な食事パターンの抽出
    中村幸男, 中村幸男
  • Wntシグナルを基盤にした関節リウマチの新たな治療戦略
  • 骨粗鬆症、骨折予防に最適な食事パターンの抽出
  • Multi-sector collaboration project for appropriate treatment management and early detection of rheumatoid arthritis.
    中村幸男, 中村幸男
  • リアルワールドデータベースを用いた妊娠後骨粗鬆症に関する研究
    中村幸男, 中村幸男
  • ロコモに対する遺伝子解析・疫学調査・力学評価に基づく無作為抽出多施設地域コホート研究
    中村幸男, 中村幸男
  • 無作為選出地域住民コホートを用いた加齢による脊柱姿勢異常の病態解明
    上原将志, 上原将志
  • スクレロスチン分泌低下に伴う大腿骨近位部骨折予防戦略
    中村幸男, 中村幸男
  • 米国骨代謝学会関連
    中村幸男, 中村幸男
  • Wntシグナルを基盤にした関節リウマチの新たな治療戦略
    中村幸男, 中村幸男
  • 先天性橈尺骨癒合症の候補原因遺伝子zmat2の生体内機能解明
    中村幸男, 中村幸男
  • 健康長寿モデル都市“長野県大町市”への取り組み
    中村幸男, 中村幸男
  • 長野県各市町村と信州大学共同による“骨粗鬆症対策”を通じた健康長寿日本一への挑戦
    中村幸男, 中村幸男
  • 先天性橈尺骨癒合症患者(長野県民)の原因遺伝子同定と機能解析
    中村幸男, 中村幸男
  • 骨形成不全症に対する骨粗鬆症治療戦略
    中村幸男, 中村幸男
  • SOS ~Stop Osteoporosis in Shinshuプロジェクト~
    中村幸男, 中村幸男
  • 健康長寿地域“大町市”作りへの取り組み市民が意欲と特性を活かせるまちづくりへの参画
    中村幸男, 中村幸男
  • 寝たきりゼロを目指した健康長寿日本一への取り組み
    中村幸男, 中村幸男
  • 骨軟骨制御におけるJAK1/2の機能解析
    中村 幸男, 中村 幸男, 日本イーライリリー, 日本イーライリリー
  • 関節リウマチ合併骨粗鬆症患者におけるミノドロネートを用いた治療戦略
    中村 幸男, 中村 幸男, 小野薬品工業, 小野薬品工業
  • 炎症性疼痛受容体発現におけるJAK1/2の機能解析
    中村 幸男, 中村 幸男, 日本イーライリリー, 日本イーライリリー
  • 関節リウマチ患者由来骨芽細胞の増殖、分化における各種薬剤の評価
    中村 幸男, 中村 幸男, アステラス製薬, アステラス製薬
  • 骨芽細胞・骨細胞に対するJAK阻害剤の効果についての研究
    中村 幸男, 中村 幸男, 日本イーライリリー, 日本イーライリリー
  • Human Genetics
  • Rheumtoid Arthritis
  • Osteoporosis
  • Osteoarthritis
  • Knee & Hip Joint Surgeries